FDA Clears InVera Infusion Device to Treat Chronic Venous Disease
April 8, 2026—InVera Medical announced FDA 510(k) clearance for the InVera infusion device for the minimally invasive treatment of diseased leg veins, including varicose veins. The device is now approved for use in the United States and European Union within its indications.
According to the company, the InVera infusion device safely and effectively provides a comfortable, nonthermal, and nonimplant alternative for the treatment of chronic venous disease.
